Terms: = Brain cancer AND FANCF, FAF, 2188, ENSG00000183161, Q9NPI8, MGC126856
8 results:
1. Occupational outcomes after high-grade or low-grade brain tumors in childhood: A Swedish, nationwide, registry-based study.
Lönnerblad M; Berglund E; Åberg M; Blomgren K
Cancer Med; 2023 Mar; 12(6):7459-7469. PubMed ID: 36419225
[TBL] [Abstract] [Full Text] [Related]
2. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
Wefel JS; Zhou R; Sulman EP; Boehling NS; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Kahalley LS; Small BJ; Scheurer ME; Bondy ML; Liu Y
J Neurooncol; 2022 Jan; 156(1):185-193. PubMed ID: 34817796
[TBL] [Abstract] [Full Text] [Related]
3. Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.
Klonowska K; Thiele EA; Grevelink JM; Thorner AR; Kwiatkowski DJ
J Med Genet; 2022 Sep; 59(9):920-923. PubMed ID: 34635572
[TBL] [Abstract] [Full Text] [Related]
4. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers.
McKeon A; Shelly S; Zivelonghi C; Basal E; Dubey D; Flanagan E; Madhavan AA; Mariotto S; Toledano M; Tracy JA; Zekeridou A; Pittock SJ
Ann Clin Transl Neurol; 2021 Feb; 8(2):425-439. PubMed ID: 33369283
[TBL] [Abstract] [Full Text] [Related]
5. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
Palsgrove DN; Brosnan-Cashman JA; Giannini C; Raghunathan A; Jentoft M; Bettegowda C; Gokden M; Lin D; Yuan M; Lin MT; Heaphy CM; Rodriguez FJ
Mod Pathol; 2018 Dec; 31(12):1787-1800. PubMed ID: 29973652
[TBL] [Abstract] [Full Text] [Related]
6. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
[TBL] [Abstract] [Full Text] [Related]
7. Conventional Tumor Markers in Cerebralspinal Fluid in Patients with Elevated Serum Tumor Markers and without Central Nervous System Malignant Diseases.
Liu ZJ; Shi Q; Lu B; Zhang Z; Tian CL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):539-542. PubMed ID: 27825410
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
[TBL] [Abstract] [Full Text] [Related]
